Short Bowel Syndrome Latest Advances

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

Journal: HIV research & clinical practice

Published: April 11, 2026

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

Journal: Bioconjugate chemistry

Published: April 10, 2026

Short Bowel Syndrome: Adaptive Mechanisms and Management Strategies in Veterinary Patients.

Journal: The Veterinary clinics of North America. Small animal practice

Published: March 24, 2026

Corrigendum to "Smooth muscle cell (SMC) Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death" [Biochem. Biophys. Rep. 44 (2025) 102298].

Journal: Biochemistry and biophysics reports

Published: March 23, 2026

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Journal: Current opinion in gastroenterology

Published: March 23, 2026

Chinese expert consensus on diagnosis and treatment of short bowel syndrome in adults (2026 version)

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: March 19, 2026

Fecal microbiota transplantation in murine models of colitis and short bowel syndrome: lessons learned, limitations, and translational perspectives.

Journal: Minerva gastroenterology

Published: March 19, 2026

Short bowel syndrome-associated intestinal failure: diagnosis and prognosis.

Journal: Expert review of gastroenterology & hepatology

Published: March 13, 2026

Successful Anesthetic Management of Orthotopic Liver Transplant in a Patient with Deoxyguanosine Kinase Deficiency: A Case Report.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: March 11, 2026

Early ecological changes in intestinal microbiota with the long-acting GLP-2 analog apraglutide in short bowel syndrome.

Journal: Clinical nutrition ESPEN

Published: March 08, 2026

Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo-obstruction.

Journal: Journal of internal medicine

Published: February 27, 2026

Rivaroxaban vs. apixaban in short bowel syndrome: a focused clinical pharmacology review.

Journal: Expert opinion on drug metabolism & toxicology

Published: February 27, 2026

Short Bowel Syndrome Latest Advances

Find the Latest Research About Short Bowel Syndrome

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in Mice.

Short Bowel Syndrome: Adaptive Mechanisms and Management Strategies in Veterinary Patients.

Short Bowel Syndrome: Adaptive Mechanisms and Management Strategies in Veterinary Patients.

Corrigendum to "Smooth muscle cell (SMC) Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death" [Biochem. Biophys. Rep. 44 (2025) 102298].

Corrigendum to "Smooth muscle cell (SMC) Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death" [Biochem. Biophys. Rep. 44 (2025) 102298].

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?

Chinese expert consensus on diagnosis and treatment of short bowel syndrome in adults (2026 version)

Chinese expert consensus on diagnosis and treatment of short bowel syndrome in adults (2026 version)

Fecal microbiota transplantation in murine models of colitis and short bowel syndrome: lessons learned, limitations, and translational perspectives.

Fecal microbiota transplantation in murine models of colitis and short bowel syndrome: lessons learned, limitations, and translational perspectives.

Short bowel syndrome-associated intestinal failure: diagnosis and prognosis.

Short bowel syndrome-associated intestinal failure: diagnosis and prognosis.

Successful Anesthetic Management of Orthotopic Liver Transplant in a Patient with Deoxyguanosine Kinase Deficiency: A Case Report.

Successful Anesthetic Management of Orthotopic Liver Transplant in a Patient with Deoxyguanosine Kinase Deficiency: A Case Report.

Early ecological changes in intestinal microbiota with the long-acting GLP-2 analog apraglutide in short bowel syndrome.

Early ecological changes in intestinal microbiota with the long-acting GLP-2 analog apraglutide in short bowel syndrome.

Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo-obstruction.

Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo-obstruction.

Rivaroxaban vs. apixaban in short bowel syndrome: a focused clinical pharmacology review.

Rivaroxaban vs. apixaban in short bowel syndrome: a focused clinical pharmacology review.